CD4 Antibody eFluor 506 69-0049-42 from Thermo Fisher Scientific

Product Specs
ItemCD4 Antibody eFluor 506
CompanyThermo Fisher Scientific
Price Supplier Page
Catalog Number69-0049-42
Quantity100 Tests
ApplicationsFlow Cytometry
Concentration5 µL/Test
Conjugate/TageFluor™ 506
FormatPBS with BSA and 0.09% sodium azide; pH 7.2
ReactivityHuman
TargetCD4
IsotypeIgG1 kappa
CloneRPA-T4
HostMouse
NCBI Full Gene NameCD4 molecule
NCBI Gene AliasesCD4mut, IMD79, Leu-3, OKT4D, T4
ClonalityMonoclonal
PurityAffinity chromatography
Storage4°C, store in dark, DO NOT FREEZE!
Antibody TypePrimary
Storage Temperature4° C, store in dark, DO NOT FREEZE!

Add to Compare List

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Lipid nanoparticles with aptamers enable targeted mRNA delivery to CD4⁺ T cellsDrug DelivDecember 31, 2026Shrey Shah, Meenakshi Ranasinghe, John Decker, Keith Fraser, Ying Wang, Sarah Kinlaw, Morgan Barker, Sawan Patel, Adam Friedman, Sherwood Yaofluorescence-labeled antibody (Human CD4 Monoclonal Antibody (RPA-T4) eFluor 506, Thermo Fisher Scientific, Cat No.69-0049-42). 3.5. Biolayer interferometry (BLI) BLI was used for the kinetic characterization of Apt62 and its

(2) Protocol for production of tonic CAR T cells with dasatinibSTAR ProtocolsMarch 1, 2025Léa Rosselle, Thibault Leray, Sandy Joaquina, Benjamin Caulier, Emmet McCormack, Pascal Gelebart, Sébastien Wälchli, Else Marit Inderberg364-0036-42 "CD4 monoclonal antibody (RPA-T4), eFluor 506 (1:100)","eBioscience, Invitrogen",Cat. No. 69-0049-42 "CD8a monoclonal antibody (RPA-T8), Brilliant Ultra Violet 563 (1:400)","eBioscience, Invitrogen",Cat.

(3) IL-4 activates ULK1/Atg9a/Rab9 in asthma, NLRP3 inflammasomes, and Golgi fragmentation by increasing autophagy flux and mitochondrial oxidative stressRedox biologyMay 1, 2024Xu C, Song Y, Liu W, Liu R, Bai Q, Li L, Wang C, Yan G.

(4) Myeloid‑derived suppressor cell accumulation induces Treg expansion and modulates lung malignancy progressionBiomedical reportsApril 1, 2024Wan Y, Mu X, Zhao J, Li L, Xu W, Zhang M.

(5) Paediatric sepsis survivors are resistant to sepsis-induced long-term immune dysfunctionBritish journal of pharmacologyApril 1, 2024Colón DF, Wanderley CW, Turato WM, Borges VF, Franchin M, Castanheira FVS, Nascimento D, Prado D, Haruo Fernandes de Lima M, Volpon LC, et al.

(6) HLA-class II restricted TCR targeting human papillomavirus type 18 E7 induces solid tumor remission in miceNature communicationsMarch 13, 2024Long J, Chen X, He M, Ou S, Zhao Y, Yan Q, Ma M, Chen J, Qin X, Zhou X, et al.

(7) miR-539-5p targets BMP2 to regulate Treg activation in B-cell acute lymphoblastic leukemia through TGF-β/Smads/MAPKExperimental biology and medicine (Maywood, N.J.)January 1, 2024Dai Q, Shi R, Zhang G, Wang Y, Ye L, Peng L, Guo S, He J, Yang H, Jiang Y.

(8) Cathepsin S inhibition in dendritic cells prevents Th17 cell differentiation in perivascular adipose tissues following vascular injury in diabetic ratsJournal of biochemical and molecular toxicologySeptember 1, 2023Peng H, Lv Y, Li C, Cheng Z, He S, Wang C, Liu J.

(9) Rapamycin improves Graves' orbitopathy by suppressing CD4+ cytotoxic T lymphocytesJCI insightFebruary 8, 2023Zhang M, Chong KK, Chen ZY, Guo H, Liu YF, Kang YY, Li YJ, Shi TT, Lai KK, He MQ, et al.

(10) Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjectsFrontiers in immunologyJanuary 1, 2023Laquintana V, Mottini C, Marchesi F, Marcozzi B, Terrenato I, Sperandio E, de Latouliere L, Carrieri F, Pimpinelli F, Pontone M, et al.

(11) Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunityNature communicationsDecember 10, 2022McEvoy CM, Murphy JM, Zhang L, Clotet-Freixas S, Mathews JA, An J, Karimzadeh M, Pouyabahar D, Su S, Zaslaver O, et al.

(12) Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 ReceptorCellsAugust 19, 2022Rode AKO, Buus TB, Mraz V, Al-Jaberi FAH, Lopez DV, Ford SL, Hennen S, Eliasen IP, Klewe IV, Gharehdaghi L, et al.

(13) Decoding the pathogenesis of Diamond-Blackfan anemia using single-cell RNA-seqCell discoveryMay 10, 2022Wang B, Wang C, Wan Y, Gao J, Ma Y, Zhang Y, Tong J, Zhang Y, Liu J, Chang L, et al.

(14) Single-cell RNA sequencing reveals the molecular features of peripheral blood immune cells in children, adults and centenariansFrontiers in immunologyJanuary 1, 2022Zhong J, Ding R, Jiang H, Li L, Wan J, Feng X, Chen M, Peng L, Li X, Lin J, et al.

(15) Aberrant gut-microbiota-immune-brain axis development in premature neonates with brain damageCell host & microbeOctober 13, 2021Seki D, Mayer M, Hausmann B, Pjevac P, Giordano V, Goeral K, Unterasinger L, Klebermaß-Schrehof K, De Paepe K, Van de Wiele T, et al.

(16) Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cellsMolecular therapy. Methods & clinical developmentSeptember 10, 2021Kierkels GJJ, van Diest E, Hernández-López P, Scheper W, de Bruin ACM, Frijlink E, Aarts-Riemens T, van Dooremalen SFJ, Beringer DX, Oostvogels R, et al.

(17) Preoperatively predicting the pathological types of acute appendicitis using machine learning based on peripheral blood biomarkers and clinical features: a retrospective studyAnnals of translational medicineMay 1, 2021Kang CB, Li XW, Hou SY, Chi XQ, Shan HF, Zhang QJ, Li XB, Zhang J, Liu TJ.Immunofluorescent-labeled antibodies were all purchased from eBioscience (San Diego, CA): anti-human CD3 (11-0037-42), CD4 (69-0049-42), CD8 (MHCD0831), CD16 (15-0168-42), CD19 (13-0199-80), and CD56 (62-0566-41). Different fluorescence

(18) Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell ActivationCancersApril 13, 2021Prat M, Salon M, Allain T, Dubreuil O, Noël G, Preisser L, Jean B, Cassard L, Lemée F, Tabah-Fish I, et al.

(19) Effects of the Antidiabetic Drugs Evogliptin and Sitagliptin on the Immune Function of CD26/DPP4 in Th1 CellsBiomolecules & therapeuticsMarch 1, 2021Yoon H, Sung JH, Song MJ.

(20) Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF InhibitionFrontiers in immunologyJanuary 1, 2021Yeku OO, Rao TD, Laster I, Kononenko A, Purdon TJ, Wang P, Cui Z, Liu H, Brentjens RJ, Spriggs D.